Navigation Links
Novel Diabetes Drug Discovery Has Potential to Reverse Disease
Date:1/27/2009

ion as a therapeutic approach. Pancreatic islets contain four primary cell types and are responsible for producing insulin, amylin, glucagon and other hormones critical to maintaining normal glucose regulation. Current diabetes therapies, including insulin, help to control the disease but do not restore new islets. HIP addresses the underlying mechanism of the pathology of diabetes and represents a potentially curative approach to both, type 1 and 2 diabetes. If successful in human clinical trials, HIP-induced restoration of islet function has the potential to become a first-line treatment approach for diabetes and pre- diabetes.

About HIP

Human proIslet Peptide (HIP) is a 14-amino acid, stabilized human peptide that stimulates the signal pathways that induce new islet formation in the pancreas, without the use of stem cells. HIP creates new insulin-producing beta cells by generating new islets that contain alpha, beta, gamma and delta cells, all of which are necessary to regulate glucose metabolism. The core patent for the HIP technology was issued in July 2008.

About CureDM

CureDM is a Biotherapeutics company focusing on Diseases of Metabolism. CureDM has developed a proprietary platform technology using genomics and proteomics to identify bioactive components of gene products that are fundamental to address unmet medical needs. HIP is the first product derived from this process with other pipeline compounds under development. CureDM, Inc. is located in the Lankenau Institute for Medical Research at the Lankenau Hospital campus in Wynnewood, PA. For further information visit www.curedm.com

About Endocrine Practice

Endocrine Practice is the peer-reviewed journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists read by more than 6000 endocrinologists. The content of En
'/>"/>

SOURCE CureDM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis
2. S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
3. Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
4. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
5. Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury
6. Medivation Presents New Data on Dimebons Novel Mechanism of Action
7. Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting
8. Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
9. ScinoPharm Granted US Patent for Novel Crystal Forms
10. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... VEGAS, Dec. 16 Cord Blood America, ... blood stem cell preservation company ( http://www.cordblood-america.com ... of stem cells, a biological insurance policy, to ... has reduced its debt by a total of ... of 2009 and total debt eliminated for the ...
(Date:12/16/2009)... biotechnology company,s revenues increase 22% for fiscal 2009; ... 2010 , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix ... virology and biological technologies, today reported financial results ... fiscal year ended September 30, 2009, Microbix reported ... the same period in 2008. For fourth-quarter 2009, ...
(Date:12/16/2009)... for the ultimate CHO cell culture supplement? InVitria has what ... cell culture media supplement that improves the growth and productivity ... culture performance, Zap-CHO is an animal free, well defined and ... ... Fort Collins, CO (PRWEB) December 16, 2009 -- Scientists working ...
(Date:12/16/2009)... will hold its 23rd Annual Technical Conference & Exhibition on March ... To further impact the separation society and reach out to even ... the 2010 AFS Annual Technical Conference will be co-located with the ... ... MN (PRWEB) December 16, 2009 -- The American Filtration and Separations ...
Breaking Biology Technology:Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... Wis. GE Healthcare said on Tuesday ... its Flowcast IT systems, which were produced by IDX before ... part of a $15 million program to create a national ... GE's web-based patient information systems, including patient financial information a ...
... ago, I wrote a column criticizing an "advice article" in ... when leaving a company. ( Ready to leave? Why ... published both on ePrairie and with the Wisconsin Technology Network ... then, there have been many comments and personal stories of ...
... legally obligated to notify customers when their personal information ... to rethink the way they both protect information and ... into law Thursday by Governor Jim Doyle, companies must ... when computer systems are hacked, when dishonest employees sell ...
Other Biology Technology:Employees debate ethics of giving two weeks' notice 2Employees debate ethics of giving two weeks' notice 3Employees debate ethics of giving two weeks' notice 4Employees debate ethics of giving two weeks' notice 5Businesses can't hide personal information losses, theft 2
(Date:12/15/2009)... and economic toll on society. It is estimated that ... in U.S. waters and it,s likely that rip currents account ... disconnect exists between rip current research and public understanding. ... and more importantly, most people do not know how to ... The goal of the Rip Current Symposium is to identify ...
(Date:12/15/2009)... Va., Dec. 15 The PTR Group, a ... announced that it has agreed to sponsor three high ... FIRST Robotics Competition ( http://usfirst.org ). ,, ... school teams in three different states. The teams ... Rockwall, TX, and James Madison HS in Vienna, VA ...
(Date:12/14/2009)... at Rice University and Baylor College of Medicine (BCM) ... in real time with MRI as it homes in ... and kills them with heat. The all-in-one particle is ... called "theranostics" that develops technologies physicians can use to ... The research is available online in the journal ...
Breaking Biology News(10 mins):The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Tracking new cancer-killing particles with MRI 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 1NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 3Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 1Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 2Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 3Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 4JustColleges Launches a Health Care Education Channel for Students 59717 1JustColleges Launches a Health Care Education Channel for Students 59717 2JustColleges Launches a Health Care Education Channel for Students 59717 3JustColleges Launches a Health Care Education Channel for Students 59717 4
... novel,vaccine that uses immune cells as factories to produce ... breast cancers, say researchers at,The University of Texas M. ... is a protein often present / surexpressed in ... Breast Cancer Research,on Nov. 29, 2004, showed that the ...
... the journal Nature that the "missing" genes for tRNA ... together sequences in distant parts of the DNA genome. ... the Department of Molecular Biophysics and Biochemistry at Yale ... genome sequence. Nanoarchaeum equitans, is a member of a ...
... on successful animal studies, a novel,vaccine that uses immune ... way to treat some human breast cancers, say researchers ... [Ed : Her2/neu is a protein often ... published in the online journal, Breast Cancer Research,on Nov. ...
Other Biology News:A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 2A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 3Researchers find missing genes of ancient organism 2Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer 2Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer 3
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Request Info...
Request Info...
Request Info...
Biology Products: